13F

Stock

Armata Pharmaceuticals, Inc.

ARMP · held by 36 managers

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025

Reported value

$7.85M

Holders

36

+0 new · −1 exited

Holders’ est. mark

$4.74K

Price effect on 3 books still in the name

Largest holder

$2.25M

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard357.6K$2.25M—Held
683 Capital Management, LLC139.9K$878.3K—Held
GEODE CAPITAL MANAGEMENT, LLC109.9K$690.3K—Held
EDGEWOOD MANAGEMENT LLC100K$628K—Held
BlackRock, Inc.72.8K$457K—Held
Renaissance Technologies68.5K$430.2K—Held
State Street50.8K$319K—Held
GOLDMAN SACHS GROUP INC45.2K$283.6K—Held
BRIDGEWAY CAPITAL MANAGEMENT, LLC44.7K$280.6K—Held
SeaCrest Wealth Management, LLC41K$273.8K—Held
Grey Ledge Advisors, LLC30K$188.4K—Held
OMERS ADMINISTRATION Corp28.1K$176.6K—Held
MILLENNIUM MANAGEMENT LLC26.1K$163.8K—Held
NORTHERN TRUST CORP24.6K$154.8K—Held
SUSQUEHANNA INTERNATIONAL GROUP, LLP24.4K$153K—Held
Qube Research & Technologies Ltd23.4K$146.7K—Held
JANE STREET GROUP, LLC17.2K$107.7K—Held
CAPTRUST FINANCIAL ADVISORS13.1K$82.5K—Held
Citadel10.8K$67.7K—Held
Dauntless Investment Group, LLC6.13K$38.5K—Held
BANK OF AMERICA CORP /DE/3.52K$22.1K$23Added$22.1K
MORGAN STANLEY2.27K$14.3K$7Added$14.2K
Tower Research Capital LLC (TRC)1.6K$10.1K—Held
Cornerstone National Bank & Trust Co1.43K$8.97K$4.71KAdded$4.71K
UBS Group AG1.02K$6.41K—Held
Measured Wealth Private Client Group, LLC1K$6.28K—Held
Trifecta Capital Advisors, LLC714$4.48K—Held
BNP PARIBAS FINANCIAL MARKETS710$4.46K—Held
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO571$3.59K—Held
OSAIC HOLDINGS, INC.357$2.24K—Held
WHITTIER TRUST CO100$587—Held
Geneos Wealth Management Inc.92$578—Held
MAI Capital Management71$446—Held
Team Financial Group, LLC71$446—Held
SBI Securities Co., Ltd.3$19—Held
WELLS FARGO & COMPANY/MN1$3—Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.